Mammographic density (MD) is a strong risk factor for breast cancer and family studies suggest it is highly heritable. Genome wide association studies (GWAS) have identified a modest number of loci for MD, some of which overlap with breast cancer risk. However, most of the heritability of breast cancer remains unexplained and the underlying biology that explains the overlap between density and breast cancer risk remains poorly understood. This proposal will support Dr. Elad Ziv to continue scientific work on the genetics of mammographic density and to continue to mentor clinician investigators in translational genetic studies of cancer. As part of the current cycle of this K24, Dr. Ziv and his colleagues have investigated the genetics of breast cancer and MD in Latina women. They have identified, via admixture mapping and GWAS, a very strong association for a single nucleotide polymorphism (SNP) on chromosome 6q25. The minor allele at of this SNP is associated with substantially reduced risk of breast cancer (Odds ratio of 0.6 for heterozygotes and 0.2 for homozygotes). They also found that the minor allele is associated with a substantial reduction of mammographic density; comparing women homozygous for the common allele vs. women homozygous for the low risk minor allele, the median percent mammographic density is reduced from 16% to 8%, respectively. This SNP is found almost exclusively in Latina women since this it originates in the Indigenous American populations from that region. These results demonstrate the value of genetic studies in non-Caucasian populations for complex traits. As part of the renewal for this project, they aim to extend these studies. They will focus on Latinas, a relatively understudied population, where they have developed unique resources including a large GWAS and whole exome sequencing data. First, they will investigate the possibility that rare variants at the 6q25 locus are associated with MD in Latina women. They will perform targeted capture and sequencing of the region they have previously found to be associated with breast cancer and density and they will perform rare variant association tests. Second, they will use GWAS data from Latina women with breast cancer and controls to determine what genes and pathways might be involved in the overlap between breast density and breast cancer risk. Third, they will use data from their exome sequencing project (R01CA184545) to investigate whether rare variants in coding regions in genes might underlie the shared heritability between MD and breast cancer. Dr. Ziv will also continue to mentor junior faculty, post-doctoral fellows, residents and students in research. Mentees will work on the aims listed in this proposal and on several other large projects on genetic susceptibility to breast cancer, genetics of mammographic density and genetics of multiple myeloma.

Public Health Relevance

Mammographic density is a strong risk factor for breast cancer. Family studies suggest that most of the variation in mammographic density is due to genetic factors. However, to date very few of the genetic factors underlying mammographic density are known. We propose to investigate this shared genetic basis for both of these traits using unique datasets that we have developed as part of several collaborative studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24CA169004-07
Application #
9445393
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Radaev, Sergey
Project Start
2012-08-09
Project End
2022-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
7
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Wu, Yi-Hsuan; Graff, Rebecca E; Passarelli, Michael N et al. (2018) Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics. Cancer Epidemiol Biomarkers Prev 27:75-85
Hoffman, Joshua D; Graff, Rebecca E; Emami, Nima C et al. (2017) Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. PLoS Genet 13:e1006690
Michailidou, Kyriaki (see original citation for additional authors) (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551:92-94
Ziv, Elad; Tice, Jeffrey A; Sprague, Brian et al. (2017) Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS One 12:e0168601
Milne, Roger L (see original citation for additional authors) (2017) Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet 49:1767-1778
Shieh, Yiwey; Hu, Donglei; Ma, Lin et al. (2017) Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast Cancer Res Treat 166:603-612
Shieh, Yiwey; Hu, Donglei; Ma, Lin et al. (2016) Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat 159:513-25
Rand, Kristin A; Song, Chi; Dean, Eric et al. (2016) A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev 25:1609-1618
Vachon, Celine M; Pankratz, V Shane; Scott, Christopher G et al. (2015) The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 107:
Torres-Mejía, Gabriela; Royer, Robert; Llacuachaqui, Marcia et al. (2015) Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomarkers Prev 24:498-505

Showing the most recent 10 out of 21 publications